Myriad Genetics (MYGN)

Myriad Genetics (MYGN) Stock Price & Analysis


MYGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$13.92 - $24.21
Previous Close$16.04
Average Volume (3M)512.27K
Market Cap
Enterprise Value$1.40B
Total Cash (Recent Filing)$121.60M
Total Debt (Recent Filing)$203.80M
Price to Earnings (P/E)-5.3
Oct 31, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.05
Shares Outstanding81,883,426
10 Day Avg. Volume663,623
30 Day Avg. Volume512,268
Standard Deviation0.17
Financial Highlights & Ratios
Price to Book (P/B)14.72
Price to Sales (P/S)7.16
Price to Cash Flow (P/CF)-19.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.00
Enterprise Value/Gross Profit2.93
Enterprise Value/Ebitda-7.16
Price Target Upside49.63% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Myriad Genetics’s price range in the past 12 months?
Myriad Genetics lowest stock price was $13.92 and its highest was $24.21 in the past 12 months.
    What is Myriad Genetics’s market cap?
    Currently, no data Available
    When is Myriad Genetics’s upcoming earnings report date?
    Myriad Genetics’s upcoming earnings report date is Oct 31, 2023 which is in 29 days.
      How were Myriad Genetics’s earnings last quarter?
      Myriad Genetics released its earnings results on Aug 03, 2023. The company reported -$0.08 earnings per share for the quarter, beating the consensus estimate of -$0.081 by $0.001.
        Is Myriad Genetics overvalued?
        According to Wall Street analysts Myriad Genetics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Myriad Genetics pay dividends?
          Myriad Genetics pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Myriad Genetics dividends here
            What is Myriad Genetics’s EPS estimate?
            Myriad Genetics’s EPS estimate is -$0.08.
              How many shares outstanding does Myriad Genetics have?
              Myriad Genetics has 81,883,420 shares outstanding.
                What happened to Myriad Genetics’s price movement after its last earnings report?
                Myriad Genetics reported an EPS of -$0.08 in its last earnings report, beating expectations of -$0.081. Following the earnings report the stock price went down -6.985%.
                  Which hedge fund is a major shareholder of Myriad Genetics?
                  Among the largest hedge funds holding Myriad Genetics’s share is Glenview Capital Management LLC. It holds Myriad Genetics’s shares valued at 87M.


                    Myriad Genetics Stock Smart Score

                    The Myriad Genetics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Myriad Genetics

                    Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic test. It operates through the Diagnostics and Other segments. The Diagnostics segment provides testing and collaborative development of testing that is designed to asses an individual's risk of developing a disease later in life. The Other segment offers products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients; and also includes corporate services such as finance, human resources, legal, and information technology. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.


                    Top 5 ETFs holding MYGN

                    Market Value
                    Smart Score
                    Vanguard Total Stock Market ETF
                    Vanguard Russell 3000 ETF
                    SPDR S&P 1500 Value Tilt ETF
                    V-Shares US Leadership Diversity ETF
                    Invesco S&P US Total Market ESG Tilt Index ETF Trust Units -CAD Hedged-
                    Up to five ETFs with an Outperform Smart Score that hold MYGN. The ETFs are listed according to market value of MYGN within the ETF

                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Thermo Fisher
                    Quest Diagnostics

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis